Ranjini K Sundaram

6PUBLICATIONS
62CO-AUTHORS
Haematological tumoursCellular nervous systemMolecular targetsGene and molecular therapyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jul 17, 2026
Leveraging Homologous Recombination Deficiency via the Repositioned Prodrug CB1954.

|Apr 22, 2026
NAPRT expression and epigenetic regulation in pediatric rhabdomyosarcoma as a potential biomarker for NAMPT inhibition.

|Jul 01, 2024
NAPRT Silencing in FH-Deficient Renal Cell Carcinoma Confers Therapeutic Vulnerabilities via NAD+ Depletion.

Katelyn J Noronha, Karlie N Lucas, Sateja Paradkar

|May 01, 2024
Exploiting Metabolic Defects in Glioma with Nanoparticle-Encapsulated NAMPT Inhibitors.

Matthew A Murray, Katelyn J Noronha, Yazhe Wang

|Jul 28, 2022
Mechanism-based design of agents that selectively target drug-resistant glioma.

Kingson Lin, Susan E Gueble, Ranjini K Sundaram

|Apr 19, 2022
TOP1-DNA Trapping by Exatecan and Combination Therapy with ATR Inhibitor.

Ukhyun Jo, Yasuhisa Murai, Keli K Agama

Pageof 1

Frequent Collaborators

5 joint publications

Ranjit S Bindra

3 joint publications

Katelyn J Noronha

3 joint publications

Karlie N Lucas

3 joint publications

Juan C Vasquez